Aggrecanase-1 and -2 (ADAMTS-4 and ADAMTS-5) are zinc metalloproteases involved in the degradation of aggrecan in cartilage. Inhibitors could provide a means of altering the progression of osteoarthritis. We report the identification of 7 which had good oral pharmacokinetics in rats and showed efficacy in a rat chemical model of osteoarthritis. The projected human dose required to achieve sustained plasma levels ≥10 times the hADAMTS-5 IC is 5 mg q.d.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/acs.jmedchem.7b00650 | DOI Listing |
Publication Analysis
Top Keywords
projected human
8
human dose
8
highly selective
4
selective hydantoin
4
hydantoin inhibitor
4
inhibitor aggrecanase-1
4
aggrecanase-1 aggrecanase-2
4
aggrecanase-2 low
4
low projected
4
dose aggrecanase-1
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!